In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Zoetis Inc (NYSE: ZTS) closed the day trading at $118.16 down -0.41% from the previous closing price of $118.65. In other words, the price has decreased by -$0.41 from its previous closing price. On the day, 5.27 million shares were traded. ZTS stock price reached its highest trading level at $120.15 during the session, while it also had its lowest trading level at $117.5223.
Ratios:
For a better understanding of ZTS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 24.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.25. For the most recent quarter (mrq), Quick Ratio is recorded 2.28 and its Current Ratio is at 3.64. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.35.
On July 17, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $155.
Stifel Downgraded its Buy to Hold on June 18, 2025, while the target price for the stock was maintained at $160.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’25 when Lagano Roxanne sold 652 shares for $170.00 per share. The transaction valued at 110,840 led to the insider holds 15,129 shares of the business.
Lagano Roxanne bought 652 shares of ZTS for $110,840 on Jun 03 ’25. On Mar 11 ’25, another insider, Reed Willie M, who serves as the Director of the company, bought 1,210 shares for $166.14 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 52366561280 and an Enterprise Value of 57494249472. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.91, and their Forward P/E ratio for the next fiscal year is 17.38. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.54 while its Price-to-Book (P/B) ratio in mrq is 9.66. Its current Enterprise Value per Revenue stands at 6.118 whereas that against EBITDA is 14.406.
Stock Price History:
The Beta on a monthly basis for ZTS is 0.97, which has changed by -0.32856095 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, ZTS has reached a high of $181.85, while it has fallen to a 52-week low of $115.25. The 50-Day Moving Average of the stock is -11.54%, while the 200-Day Moving Average is calculated to be -21.72%.
Shares Statistics:
Over the past 3-months, ZTS traded about 3.87M shares per day on average, while over the past 10 days, ZTS traded about 5090720 shares per day. A total of 441.46M shares are outstanding, with a floating share count of 439.89M. Insiders hold about 0.18% of the company’s shares, while institutions hold 96.84% stake in the company. Shares short for ZTS as of 1763078400 were 8251796 with a Short Ratio of 2.13, compared to 1760486400 on 8734430. Therefore, it implies a Short% of Shares Outstanding of 8251796 and a Short% of Float of 1.87.
Dividends & Splits
ZTS’s forward annual dividend rate is 2.00, up from 1.932 a year ago. Against a Trailing Annual Dividend Yield of 0.016283186. The stock’s 5-year Average Dividend Yield is 0.82.
Earnings Estimates
The dynamic stock of Zoetis Inc (ZTS) is currently attracting attention from 15.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $1.57, with high estimates of $1.62 and low estimates of $1.51.
Analysts are recommending an EPS of between $6.38 and $6.3 for the fiscal current year, implying an average EPS of $6.34. EPS for the following year is $6.79, with 19.0 analysts recommending between $6.96 and $6.43.
Revenue Estimates
13 analysts predict $2.36B in revenue for. The current quarter. It ranges from a high estimate of $2.39B to a low estimate of $2.34B. As of. The current estimate, Zoetis Inc’s year-ago sales were $2.32BFor the next quarter, 13 analysts are estimating revenue of $2.33B. There is a high estimate of $2.36B for the next quarter, whereas the lowest estimate is $2.27B.
A total of 16 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $9.51B, while the lowest revenue estimate was $9.42B, resulting in an average revenue estimate of $9.44B. In the same quarter a year ago, actual revenue was $9.26BBased on 17 analysts’ estimates, the company’s revenue will be $9.94B in the next fiscal year. The high estimate is $10.13B and the low estimate is $9.74B.
